3sbio (SSRS) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access SSRS quarterly Cash Flow →
Cash flow data covering 3sbio– offers a view into how Dec 31 2012's cash position has developed alongside business activity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2012)
12 Months
(Dec 31 2009)
Operating Activities
Income16.43
Depreciation & amortization3.86
Amortization of Other Assets0.61
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.02
Increase (Decrease) in Inventories1.24
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-0.04
Share-based Compensation3.67
Income (Loss) from Equity Method Investments-0.11
Financial Instruments and Foreign Currency Transaction-0.71
Amortization Of Prepaid L and Use Rights-
Amortization Of Deferred Grant Income-
Available For Sale Securities Gross Realized Gains Losses Sale Proceeds-
Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities-
Increase Decrease Long Term Receivables-
Increase Decrease In Deferred Grant Income-
Income taxes-0.91
Gain (Loss) on Sale of Investments-1.23
Accounts Receivable0.21
Increase (Decrease) in Accounts Payable-0.39
Increase (Decrease) in Accrued Liabilities3.24
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.20
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.04
Payments for (Proceeds from) Other Operating Activities1.79
Discontinued operations0.00
Net Cash flow from Operating Activities29.85
Investing Activities
Capital Expenditures1.34
Sale of Capital Items0.07
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Issuance Of Short Term Loan-
Repayment Of Short Term Loan-
Payments For Prepaid L and Use Rights-
Purchase Of Time Deposits-
Proceeds From Disposal Of Time Deposits-
Release Of Cash In Restriction For Investment In A Subsidiary-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Payments to Acquire Equity Method Investments0.79
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net12.47
Discontinued operations0.00
Net Cash Flow from Investing Activities3.16
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.08
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.08
Effect of exchange rate on cash flow-0.23
Discontinued operations0.00
Free Cash Flow31.26
Total Cash Flow32.86
4 historic quarters locked

Sign in to unlock the full 3sbio cash flow history.

About SSRS Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License